Fred Bazzoli - Healthcare IT writer, former editor for several healthcare IT publications, past Communications Director for both CHIME and HIMSS

Recap of the April HL7 Da Vinci Project Community Roundtable

Benjamin Powers

Miriam Gonzalez initially saw the posters around the hospital where she worked. They depicted a diverse range of people that actually represented the American population—not something she usually saw in medical ads.

David Raths

The project is still in its formative stages. Published notes from a kickoff meeting for Vulcan held last fall describe its goals of helping the research community leverage FHIR for more effective acquisition, exchange and use of data for clinical research.

At the meeting Wayne Kubick, HL7’s chief technology officer, suggested several use cases for research:

• Feasibility, instigator and subject searches

Robert Grossman - Data Scientist at the University of Chicago, Director of the Open Commons Consortium

We Need Three Types of Large-Scale COVID-19 Testing

The importance of COVID-19 testing is now more than clear to everyone, but what may not be so obvious is what type of testing is required, what the tests tell us, and what we can do with the data.

Large scale, robust testing needs to answer three critical questions to inform an appropriate public health response:

Phil Bourne, PhD - Stephenson Dean of the School of Data Science, Professor of Biomedical Engineering at the University of Virginia

These are unprecedented times and the School of Data Science (SDS) team–students, faculty and staff–have gone above and beyond in response to the COVID-19 pandemic. I am heartfelt and extremely proud of every one of them.

Christopher P. Austin, MD, Director, NCATS

We believe that a centralized, open-access data portal, with oversight through a scientific committee, of a limited data set of COVID-19 clinical data would be a critical resource to help address questions related to COVID19.